Testing effectiveness (Phase 2)WithdrawnNCT00837174What this trial is testingRelapsed and/or Refractory Non-Hodgkin Lymphoma StudyWho this might be right forNon-Hodgkin Lymphoma The Methodist Hospital Research Institute
Very early researchUnknownNCT04028440What this trial is testingΓδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)Who this might be right forNon-Hodgkin's LymphomaRelapsed or Refractory B Cell Non-Hodgkin's LymphomaChronic Lymphoblastic Leukemia+1 more Institute of Hematology & Blood Diseases Hospital, China 6
Very early researchTemporarily pausedNCT04697290What this trial is testingCD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.Who this might be right forB-cell Non-Hodgkin's Lymphoma Beijing Tsinghua Chang Gung Hospital 12
Not applicableLooking for participantsNCT06961669What this trial is testingIntravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell LymphomaWho this might be right forLymphoblastic LeukemiaRelapsed or Refractory Multiple Myeloma (RRMM) Anhui Provincial Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT00742495What this trial is testingPharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.Who this might be right forRelapsed or Refractory T-cell Acute Lymphoblastic LeukaemiaB-cell Precursor Acute Lymphoblastic LeukaemiaT-cell Non-Hodgkin's Lymphoma Mundipharma Research Limited 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06886139What this trial is testingTRS005 in Patients With CD20-positive R/R DLBCL.Who this might be right forCD20-positive Diffuse Large B-Cell Lymphoma Zhejiang Teruisi Pharmaceutical Inc. 139
Testing effectiveness (Phase 2)Study completedNCT02624492What this trial is testingTo Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCLWho this might be right forLymphoma, Large B-Cell, Diffuse Boehringer Ingelheim 21
Testing effectiveness (Phase 2)Study completedNCT06539195What this trial is testingDZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)Who this might be right forDiffuse Large B Cell Lymphoma Dizal Pharmaceuticals 59
Early research (Phase 1)Study completedNCT03440567What this trial is testingAvelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Mantle Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+2 more City of Hope Medical Center 16
Early research (Phase 1)Ended earlyNCT00103272What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic CancerWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+32 more National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Study completedNCT00211276What this trial is testingONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's LymphomaWho this might be right forLymphoma, B-Cell Eisai Inc. 50
Very early researchUnknownNCT04412174What this trial is testingGC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- NHLWho this might be right forB-cell Non Hodgkin Lymphoma Hebei Yanda Ludaopei Hospital 18
Early research (Phase 1)Study completedNCT01943682What this trial is testingSafety Study of CPX-351 in Children With Relapsed Leukemia or LymphomaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBurkitt Lymphoma+5 more Children's Hospital Medical Center, Cincinnati 27
Early research (Phase 1)Looking for participantsNCT07570017What this trial is testingRocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaWho this might be right forDLBCL Guangzhou Lupeng Pharmaceutical Company LTD. 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07607925What this trial is testingEvaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHLWho this might be right forLymphoma, Non-Hodgkin GlaxoSmithKline 49
Not applicableStudy completedNCT04697160What this trial is testingObservational Retrospective Cohort Study of Systemic Therapies for R/R DLBCLWho this might be right forDiffuse Large B Cell Lymphoma MorphoSys AG 3,573
Testing effectiveness (Phase 2)Active Not RecruitingNCT05020015What this trial is testingTAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)Who this might be right forRelapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) Takeda 27
Testing effectiveness (Phase 2)Study completedNCT00005040What this trial is testingArsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT05253118What this trial is testingRelapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)Who this might be right forDLBCL Seoul National University Hospital 28
Early research (Phase 1)Looking for participantsNCT06565689What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012Who this might be right forRelapsed or Refractory B-Cell Non-Hodgkin Lymphoma Excyte Biopharma Ltd 48